Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover pharmacokinetic comparison of ReFacto and Advate in hemophilia A
2004-003727-12Phase 4Completed
- Sponsor
- Wyeth
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of recombinant human coagulation factor VIII in hemophilia A (2 arms), sponsored by Wyeth. Primary endpoint: Area under the plasma FVIII:C versus time curve for 48 hours. Started Feb 2005; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2004-003727-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003727-12.